Table 5.
Factors associated with development of healthcare-associated infections.
| Odds ratio | 95% CI | p | |
|---|---|---|---|
| Age | 0.99 | 0.96–1.01 | 0.58 |
| Male gender | 0.76 | 0.37–1.53 | 0.45 |
| DM | 1.29 | 0.62–2.69 | 0.48 |
| ESRD | 1.05 | 0.24–4.55 | 0.94 |
| COPD | 0.82 | 0.38–1.77 | 0.62 |
| Cancer | 1.36 | 0.37–4.98 | 0.63 |
| Hydroxychloroquine* | 2.96 | 1.00–8.86 | 0.05 |
| Steroids* | 3.79 | 1.44–10.01 | 0.007 |
| Tocilizumab* | 5.04 | 2.39–10.65 | < 0.001 |
| Convalescent plasma | 1.86 | 0.88–3.92 | 0.10 |
| Central venous catheter | 2.47 | 0.87–6.97 | 0.088 |
| Mechanical ventilation | 1.11 | 0.34–3.54 | 0.86 |
| AKI requiring hemodialysis* | 3.67 | 1.05–12.80 | 0.04 |
| Antibiotics on admission | 1.02 | 0.31–3.32 | 0.96 |
| SOFA score >2 on admission | 1.21 | 0.52–2.76 | 0.65 |
Abbreviations: DM, diabetes mellitus; ESRD, end-stage renal disease; COPD, chronic obstructive pulmonary disease; AKI, acute kidney injury; SOFA, Sequential Organ Failure Assessment.